Leukoreduced blood transfusion does not increase circulating soluble markers of inflammation: a randomized controlled trial.
Jiwaji Z, Nunn KP, Conway-Morris A, Simpson AJ, Wyncoll D, Rossi AG, Walsh TS; RELIEVE Trial Investigators.
Jiwaji Z, et al.
Transfusion. 2014 Oct;54(10):2404-11. doi: 10.1111/trf.12669. Epub 2014 May 5.
Transfusion. 2014.
PMID: 24796937
Clinical Trial.
Plasma was sampled at baseline, 6 hours, and 24 hours after randomization or transfusion, and concentrations of interleukin (IL)-1beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12-p70, interferon-gamma, tumor necrosis factor-alpha, human neutrophil elastase, soluble L-selectin, an …
Plasma was sampled at baseline, 6 hours, and 24 hours after randomization or transfusion, and concentrations of interleukin (IL)-1beta, IL-2 …